Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Aug-24 4:30 PM View:  | Ars Pharmaceuticals, Inc. (SPRY) | 26-Aug-24 | Private Sale | 83,695 | $13.00 | $1,088,040.00 | (< 1%) 8.37M to 8.29M | |
| 23-Aug-24 6:41 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 23-Aug-24 | Sale Duplicate | 69,500 | $13.03 | $905,585.00 | (< 1%) 8.44M to 8.37M | |
| 23-Aug-24 6:41 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 22-Aug-24 | Sale Duplicate | 391,482 | $12.94 | $5,065,780.00 | (4%) 8.83M to 8.44M | |
| 23-Aug-24 6:41 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 21-Aug-24 | Private Sale Duplicate | 407,700 | $13.56 | $5,526,600.00 | (4%) 9.24M to 8.83M | |
| 20-May-24 8:09 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-May-24 | Disposition (change in control) Duplicate | 2,680,500 | -- | -- | (100%) 2.68M to 0 | |
| 25-Jan-24 4:32 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 23-Jan-24 | Private Purchase Duplicate | 454,545 | $11.00 | $5,000,000.00 | 3% 14.3M to 14.76M | |
| 16-Jan-24 4:36 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 11-Jan-24 | Exercise (in-the money or at-the-money) | 145,251 | $12.74 | $1,850,500.00 | 6% 2.54M to 2.68M | |
| 29-Dec-23 4:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 28-Dec-23 | Sale Duplicate | 1,364,850 | $18.35 | $25,049,000.00 | (35%) 3.9M to 2.54M | |
| 29-Dec-23 4:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 27-Dec-23 | Private Sale Duplicate | 181,498 | $19.96 | $3,622,700.00 | (4%) 4.08M to 3.9M | |
| 31-Aug-23 5:18 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 29-Aug-23 | Purchase | 500,000 | $6.20 | $3,100,000.00 | 6% 8.74M to 9.24M | |
| 16-Sep-22 4:34 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 16-Sep-22 | Private Purchase Duplicate | 484,496 | $10.32 | $5,000,000.00 | 4% 13.82M to 14.3M | |
| 20-May-22 4:32 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 18-May-22 | Private Purchase | 138,000 | $7.21 | $994,980.00 | 1% 13.68M to 13.82M | |
| 30-Dec-21 8:55 PM View: | Janux Therapeutics, Inc. (JANX) | 29-Dec-21 | Sale | 40,400 | $20.30 | $820,120.00 | (2%) 2.53M to 2.49M | |
| 23-Dec-21 4:08 PM View: | Janux Therapeutics, Inc. (JANX) | 21-Dec-21 | Sale | 119,400 | $19.00 | $2,268,600.00 | (5%) 2.65M to 2.53M | |
| 17-Dec-21 5:16 PM View: | Janux Therapeutics, Inc. (JANX) | 16-Dec-21 | Sale Duplicate | 393,300 | $19.07 | $7,500,230.00 | (13%) 3.04M to 2.65M | |
| 22-Sep-21 10:00 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 20-Sep-21 | Market Sale | 1,109,640 | $6.09 | $6,757,730.00 | (14%) 8.05M to 6.94M | (12%) |
| 21-Sep-21 10:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 17-Sep-21 | Market Purchase | 1,010,640 | $9.40 | $9,499,990.00 | 33% 3.07M to 4.08M | 10% |
| 16-Jun-21 6:20 PM View: | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Conversion Duplicate | 2,336,910 | -- | -- | 100% 0 to 2.34M | |
| 16-Jun-21 6:20 PM View: | Janux Therapeutics, Inc. (JANX) | 15-Jun-21 | Purchase Duplicate | 705,853 | $17.00 | $11,999,500.00 | 30% 2.34M to 3.04M | |
| 31-Mar-21 7:11 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 30-Mar-21 | Conversion Duplicate | 13,002,800 | -- | -- | 4103% 316.9K to 13.32M | |
| 31-Mar-21 7:11 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 30-Mar-21 | Purchase Duplicate | 359,375 | $16.00 | $5,750,000.00 | 3% 13.32M to 13.68M | |
| 19-Feb-21 4:47 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 17-Feb-21 | Market Purchase | 1,285,710 | $3.50 | $4,500,000.00 | 19% 6.77M to 8.05M | 7% |
| 19-Feb-21 6:50 PM View: | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 3,278,530 | -- | -- | 100% 0 to 3.28M | |
| 19-Feb-21 6:50 PM View: | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Purchase | 1,666,670 | $18.00 | $30,000,000.00 | 51% 3.28M to 4.95M | |
| 26-Jan-21 5:05 PM View: | Prevail Therapeutics Inc. (PRVL) | 22-Jan-21 | Disposition (change in control) | 13,822,500 | -- | -- | (100%) 13.82M to 0 | |
| 30-Dec-20 4:38 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 28-Dec-20 | Market Sale | 600,000 | $14.25 | $8,550,000.00 | (16%) 3.67M to 3.07M | 8% |
| 08-Dec-20 8:43 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-Dec-20 | Conversion Duplicate | 7,011,760 | -- | -- | 1302% 538.65K to 7.55M | |
| 08-Dec-20 8:43 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-Dec-20 | Purchase Duplicate | 1,190,480 | $21.00 | $25,000,000.00 | 16% 7.55M to 8.74M | |
| 29-Sep-20 4:38 PM View: | Pmv Pharmaceuticals, Inc. (PMVP) | 29-Sep-20 | Conversion | 6,114,330 | -- | -- | 644% 950.0K to 7.06M | |
| 29-Sep-20 4:38 PM View: | Pmv Pharmaceuticals, Inc. (PMVP) | 25-Sep-20 | Purchase Duplicate | 950,000 | $18.00 | $17,100,000.00 | 100% 0 to 950.0K | |
| 24-Jan-20 6:44 PM View: | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 5,316,360 | $68.00 | $361,512,000.00 | (100%) 5.32M to 0 | |
| 08-Aug-19 5:00 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 06-Aug-19 | Market Purchase Duplicate | 142,656 | $3.51 | $500,723.00 | 2% 6.62M to 6.77M | 13% |
| 01-Jul-19 6:16 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 01-Jul-19 | Market Purchase Duplicate | 59,243 | $3.91 | $231,640.00 | < 1% 6.57M to 6.62M | 1% |
| 01-Jul-19 6:16 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 28-Jun-19 | Market Purchase Duplicate | 565,178 | $3.72 | $2,102,460.00 | 9% 6.0M to 6.57M | 6% |
| 01-Jul-19 6:16 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 27-Jun-19 | Market Purchase Duplicate | 32,923 | $3.34 | $109,963.00 | < 1% 5.97M to 6.0M | 18% |
| 26-Jun-19 4:56 PM View: | Prevail Therapeutics Inc. (PRVL) | 24-Jun-19 | Conversion Duplicate | 10,510,100 | -- | -- | 433% 2.43M to 12.94M | |
| 26-Jun-19 4:56 PM View: | Prevail Therapeutics Inc. (PRVL) | 24-Jun-19 | Purchase Duplicate | 882,352 | $17.00 | $15,000,000.00 | 7% 12.94M to 13.82M | |
| 23-Jan-19 6:01 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-Jan-19 | Market Purchase Duplicate | 372,439 | $5.37 | $2,000,000.00 | 11% 3.3M to 3.67M | 198% |
| 13-Dec-18 6:37 PM View: | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion Duplicate | 3,952,720 | -- | -- | 100% 0 to 3.95M | |
| 13-Dec-18 6:37 PM View: | Synthorx, Inc. (THOR) | 11-Dec-18 | Purchase Duplicate | 1,363,640 | $11.00 | $15,000,000.00 | 34% 3.95M to 5.32M | |
| 06-Jun-18 6:16 PM View: | Adaptimmune Therapeutics plc (ADAP) | 06-Jun-18 | Market Sale Duplicate | 1,600 | $13.49 | $21,584.00 | (< 1%) 4.9M to 4.9M | 60% |
| 06-Jun-18 6:16 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jun-18 | Market Sale Duplicate | 17,100 | $13.57 | $232,047.00 | (< 1%) 4.92M to 4.9M | 60% |
| 01-Jun-18 5:27 PM View: | Adaptimmune Therapeutics plc (ADAP) | 01-Jun-18 | Market Sale Duplicate | 50,000 | $13.49 | $674,500.00 | (1%) 4.97M to 4.92M | 60% |
| 01-Jun-18 5:27 PM View: | Adaptimmune Therapeutics plc (ADAP) | 30-May-18 | Market Sale Duplicate | 121,000 | $13.52 | $1,635,920.00 | (2%) 5.09M to 4.97M | 60% |
| 16-May-18 5:26 PM View: | Adaptimmune Therapeutics plc (ADAP) | 14-May-18 | Market Sale Duplicate | 10,300 | $13.50 | $139,050.00 | (< 1%) 5.1M to 5.09M | 60% |
| 29-Mar-18 6:58 PM View: | Adaptimmune Therapeutics plc (ADAP) | 29-Mar-18 | Market Sale Duplicate | 31,983 | $11.53 | $368,764.00 | (< 1%) 5.13M to 5.1M | 53% |
| 29-Mar-18 6:58 PM View: | Adaptimmune Therapeutics plc (ADAP) | 27-Mar-18 | Market Sale Duplicate | 1,016,080 | $11.50 | $11,685,000.00 | (17%) 6.15M to 5.13M | 53% |
| 14-Mar-18 2:05 PM View: | Corvus Pharmaceuticals, Inc. (CRVS) | 12-Mar-18 | Private Purchase Duplicate | 588,235 | $8.50 | $5,000,000.00 | 11% 5.38M to 5.97M | |
| 26-Jul-17 5:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 24-Jul-17 | Grant Duplicate | 3,298,520 | -- | -- | 100% 0 to 3.3M | |
| 28-Mar-17 6:54 PM View: | Adaptimmune Therapeutics plc (ADAP) | 27-Mar-17 | Market Purchase Duplicate | 1,190,480 | $4.20 | $5,000,000.00 | 24% 4.96M to 6.15M | 29% |